New HIV Prevention Technologies (NPTs) were presented and discussed during a seminar on the “Social Aspects of HIV prevention technologies: Translating research into policy & practice” organised by The African Health Policy Network, with the aim to address key research questions affecting African communities
Closure of oral Tenofovir arm in VOICE Pre-Exposure Prophylaxis trial: PrEP as a “niche intervention”?
The Microbicides Trial Network (MTN) announced yesterday that its VOICE (Vaginal and Oral Interventions to Control the Epidemic, MTN003) HIV Pre-Exposure Prophylaxis (PrEP) prevention study will discontinue the daily oral tenofovir arm of the trial. The decision follows an interim review of the trial’s data
(Updated April 19, 18:00) In July 2010 the world of HIV prevention felt the first tremor of hope that the fight against the virus that causes AIDS was at a turning point in its history after the pivotal CAPRISA trial (a “game changer”) showed